Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
17.02x1.14x0.1x2.06x8.52x11.34x1.33% 7.66B
17.77x2.33x2.71x4.78x12.53x14.46x0.51% 76.62B
22.92x2.79x-1.56x4.18x12.15x14.02x2.56% 57.54B
40.86x4.23x7.2x6.3x20.46x28.26x0.58% 53.75B
49.41x6.66x1.12x13.07x28.33x35.52x-.--% 52.52B
16.58x1.41x-3.92x2.84x8.64x9.87x-.--% 25.31B
15.42x3.24x0x2.95x9.37x8.99x-.--% 18.87B
77.1x7.56x-0.04x9.19x82.5x94.64x-.--% 18.42B
264.33x58.41x5.45x94.2x143.1x145.93x - 16.49B
-21.13x - -1.09x30.7x-31.09x-30.22x-.--% 14.27B
-594.01x2.77x5.66x4.32x11.23x24.3x-.--% 12.4B
-3.55x1.34x0.3x3.06x-1.79x-1.7x-.--% 11.58B
-15.93x - -0.29x517.56x-15.7x-15.86x-.--% 10.79B
19.09x1.67x0.7x2.85x13.17x13.9x-.--% 10.18B
6.49x2.7x0.02x2.88x4.33x4.37x2.81% 8.85B
-261.95x - 0.8x - - - -.--% 8.45B
-39.37x165.67x1.07x11.79x-48.42x-42.79x-.--% 7.5B
37.98x - 0.34x16.58x38.96x39.61x-.--% 7.16B
Average -19.50x 18.71x 1.03x 42.90x 17.43x 20.86x 0.46% 23.24B
Weighted average by Cap. 10.10x 9.15x 1.52x 24.08x 19.96x 23.85x 0.63%
Biopharmaceuticals